Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-07
2006-11-07
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07132394
ABSTRACT:
The present invention relates to peptides that are parathyroid hormone (PTH) analogs, useful for the treatment of hypoparathyroidism and diseases characterized by bone mass reduction, such as osteoporosis, and for stimulating bone repair or favoring the engraftment of a bone implant; to the pharmaceutical compositions comprising these PTH-like peptides and use thereof.
REFERENCES:
patent: 5814603 (1998-09-01), Oldenburg et al.
Shimizu et al. “Parathyroid Hormone (PTH)-(1-14) and -(1-11) Analogs Conformationally Constrained by alpha-Aminoisobutyric Acid Mediate Full Agonist Responses via the Juxtamembrane Region of the PTH-1 Receptor” J. Biol. Chem. 2001, 276 (52), 49003-12.
Potts “Parathyroid hormone: past and present” J. Endocrin. 2005, 187, 311-25.
Caporale Andrea
Chorev Michael
Fiori Nereo
Mammi Stefano
Peggion Evaristo
Abiogen Pharma S.p.A.
Bradley Christina
Nixon & Peabody LLP
Tsang Cecilia J.
LandOfFree
PTH-like peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PTH-like peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PTH-like peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3660715